Eli Lilly offers new weight loss drug to some patients before FDA approval
Eli Lilly will allow a limited number of patients early access to retatrutide, its next-generation weight loss drug, before it gets FDA approval.
Eli Lilly will allow a limited number of patients early access to retatrutide, its next-generation weight loss drug, before it gets FDA approval.
Moderna’s mRNA flu vaccine gets FDA approval: Here's what's different
The Food and Drug Administration has approved a new flu vaccine made with the same mRNA technology that was used for the COVID-19 shots.
The Food and Drug Administration has approved a new flu vaccine made with the same mRNA technology that was used for the COVID-19 shots.
Corewell Teamster nurses reach tentative agreement with health system
According to the union, a 15% wage increase was agreed to over the three-year agreement with Corewell Health East on Wednesday.
According to the union, a 15% wage increase was agreed to over the three-year agreement with Corewell Health East on Wednesday.
Here's how much retiring in 2026 could cost you in health care expenses
A new Fidelity Investments analysis finds that health care costs for Americans retiring in 2026 are expected to rise 7.5% from last year.
A new Fidelity Investments analysis finds that health care costs for Americans retiring in 2026 are expected to rise 7.5% from last year.
Novo Nordisk sues rival drugmaker Eli Lilly over GLP-1 ads
Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly’s Mounjaro and Zepbound outperform Novo’s Ozempic and Wegovy.
Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly’s Mounjaro and Zepbound outperform Novo’s Ozempic and Wegovy.
Obamacare premiums going up next year - Here's why
Millions of Americans who buy health insurance through the Affordable Care Act marketplace could face another year of higher premiums in 2027.
Millions of Americans who buy health insurance through the Affordable Care Act marketplace could face another year of higher premiums in 2027.
Worried about 'Ozempic butt?' New drug could stop muscle loss tied to weight loss injections
A new drug could help people taking GLP-1 obesity drugs avoid muscle loss that often accompanies rapid weight loss.
A new drug could help people taking GLP-1 obesity drugs avoid muscle loss that often accompanies rapid weight loss.
455 charged in health care fraud crackdown; schemes totaled over $6.5 billion
Over 400 people, including 90 medical professionals, were charged in connection with medical fraud schemes, the DOJ announced.
Over 400 people, including 90 medical professionals, were charged in connection with medical fraud schemes, the DOJ announced.
Experimental pill helps people with advanced pancreatic cancer live longer, researchers say
An experimental pill helped people with one of the most deadly cancers in the world live longer, researchers reported this weekend.
An experimental pill helped people with one of the most deadly cancers in the world live longer, researchers reported this weekend.
These states spend the most on health care: See the list
A new WalletHub report found Americans are spending significantly more on health care.
A new WalletHub report found Americans are spending significantly more on health care.
CVS Caremark to cover Zepbound again after lawsuit, widespread backlash
CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk’s Wegovy.
CVS Caremark is adding Zepbound, Eli Lilly’s obesity drug, back to its commercial insurance plan formularies, more than a year after it stopped covering it in favor of Novo Nordisk’s Wegovy.
Blue Cross Blue Shield, Michigan Medicine reach contract agreement in coverage dispute
After a standoff between Blue Cross Blue Shield of Michigan and Michigan Medicine that threatened coverage for many patients, a contract agreement has been reached.
After a standoff between Blue Cross Blue Shield of Michigan and Michigan Medicine that threatened coverage for many patients, a contract agreement has been reached.
PCOS gets new name in effort to improve diagnosis for millions of women
PCOS, a chronic hormonal condition affecting 1 in 8 women around the world, is getting a new name to improve diagnosis and care.
PCOS, a chronic hormonal condition affecting 1 in 8 women around the world, is getting a new name to improve diagnosis and care.
Hantavirus in Minnesota: Officials monitor person who might have been exposed
Health officials say they are monitoring a Minnesota resident after possible exposure to hantavirus abroad.
Health officials say they are monitoring a Minnesota resident after possible exposure to hantavirus abroad.
Amazon stocking Ozempic pills at kiosks, offering same-day delivery
Amazon is making Ozempic pills more accessible and stocking its U.S. kiosks with the medication and offering same-day delivery.
Amazon is making Ozempic pills more accessible and stocking its U.S. kiosks with the medication and offering same-day delivery.
Trump says GLP-1 weight-loss drugs coming at $50 for Medicare patients
President Trump announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a cost of only $50 per month.
President Trump announced the popular GLP-1 weight loss drugs would soon be more accessible to millions of Americans at a cost of only $50 per month.
Johnson & Johnson is the latest company to list drugs on TrumpRx
Johnson & Johnson is the latest drugmaker to start selling some of its drugs on the TrumpRx website.
Johnson & Johnson is the latest drugmaker to start selling some of its drugs on the TrumpRx website.
FDA approves Foundayo, Eli Lilly's new GLP-1 obesity pill
The U.S. Food and Drug Administration has approved Eli Lilly’s new weight-loss GLP-1 pill, orforglipron, which will be sold as Foundayo.
The U.S. Food and Drug Administration has approved Eli Lilly’s new weight-loss GLP-1 pill, orforglipron, which will be sold as Foundayo.
Americans skipping meals or cutting back on other needs to afford health care, poll finds
As millions of Americans endure the financial burden of rising health care costs, some admit to making sacrifices to cover their expenses like skipping meals, according to a new poll.
As millions of Americans endure the financial burden of rising health care costs, some admit to making sacrifices to cover their expenses like skipping meals, according to a new poll.
DOJ says JD Vance comments on Medicaid funding 'have no weight'
Federal attorneys are downplaying VP JD Vance’s comments on Medicaid funding as Minnesota fights to block the Trump administration's announced pause. Read more here.
Federal attorneys are downplaying VP JD Vance’s comments on Medicaid funding as Minnesota fights to block the Trump administration's announced pause. Read more here.